Cargando…
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081866/ http://dx.doi.org/10.1186/2045-7022-4-S1-P49 |
| _version_ | 1782324166692700160 |
|---|---|
| author | Vilella, Mireia Bosque, Montserrat Trujillo, Juan Domingo, Xavier Guijarro, Elisabet Asensio, Òscar Valdesoiro, Laura Larramona, Helena Maestro, Alba Domingo, Christian |
| author_facet | Vilella, Mireia Bosque, Montserrat Trujillo, Juan Domingo, Xavier Guijarro, Elisabet Asensio, Òscar Valdesoiro, Laura Larramona, Helena Maestro, Alba Domingo, Christian |
| author_sort | Vilella, Mireia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4081866 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40818662014-07-18 PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab Vilella, Mireia Bosque, Montserrat Trujillo, Juan Domingo, Xavier Guijarro, Elisabet Asensio, Òscar Valdesoiro, Laura Larramona, Helena Maestro, Alba Domingo, Christian Clin Transl Allergy Poster Discussion Presentation BioMed Central 2014-02-28 /pmc/articles/PMC4081866/ http://dx.doi.org/10.1186/2045-7022-4-S1-P49 Text en Copyright © 2014 Vilella et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Discussion Presentation Vilella, Mireia Bosque, Montserrat Trujillo, Juan Domingo, Xavier Guijarro, Elisabet Asensio, Òscar Valdesoiro, Laura Larramona, Helena Maestro, Alba Domingo, Christian PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title | PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title_full | PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title_fullStr | PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title_full_unstemmed | PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title_short | PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| title_sort | pd49 - induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab |
| topic | Poster Discussion Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081866/ http://dx.doi.org/10.1186/2045-7022-4-S1-P49 |
| work_keys_str_mv | AT vilellamireia pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT bosquemontserrat pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT trujillojuan pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT domingoxavier pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT guijarroelisabet pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT asensiooscar pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT valdesoirolaura pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT larramonahelena pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT maestroalba pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab AT domingochristian pd49inducedsputumversusexhalednitricoxidefortheevaluationofairwayinflammationinallergicpediatricasthmapatientstreatedwithomalizumab |